NO880376L - D-gl konjugat-behandling. - Google Patents
D-gl konjugat-behandling.Info
- Publication number
- NO880376L NO880376L NO880376A NO880376A NO880376L NO 880376 L NO880376 L NO 880376L NO 880376 A NO880376 A NO 880376A NO 880376 A NO880376 A NO 880376A NO 880376 L NO880376 L NO 880376L
- Authority
- NO
- Norway
- Prior art keywords
- conjugate treatment
- treatment
- lysine
- antibody
- polymers
- Prior art date
Links
- 208000023275 Autoimmune disease Diseases 0.000 abstract 1
- WHUUTDBJXJRKMK-GSVOUGTGSA-N D-glutamic acid Chemical compound OC(=O)[C@H](N)CCC(O)=O WHUUTDBJXJRKMK-GSVOUGTGSA-N 0.000 abstract 1
- 229930182847 D-glutamic acid Natural products 0.000 abstract 1
- KDXKERNSBIXSRK-RXMQYKEDSA-N D-lysine Chemical compound NCCCC[C@@H](N)C(O)=O KDXKERNSBIXSRK-RXMQYKEDSA-N 0.000 abstract 1
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 230000000903 blocking effect Effects 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 208000035475 disorder Diseases 0.000 abstract 1
- 230000001404 mediated effect Effects 0.000 abstract 1
- 239000012528 membrane Substances 0.000 abstract 1
- 229920000642 polymer Polymers 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
- A61K51/088—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins conjugates with carriers being peptides, polyamino acids or proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
- A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
- A61K47/645—Polycationic or polyanionic oligopeptides, polypeptides or polyamino acids, e.g. polylysine, polyarginine, polyglutamic acid or peptide TAT
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2121/00—Preparations for use in therapy
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Optics & Photonics (AREA)
- Physics & Mathematics (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Medicinal Preparation (AREA)
- Treatments For Attaching Organic Compounds To Fibrous Goods (AREA)
- Peptides Or Proteins (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US86939386A | 1986-05-30 | 1986-05-30 | |
| PCT/US1987/000197 WO1987007145A1 (en) | 1986-05-30 | 1987-02-02 | D-gl conjugate therapy |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO880376D0 NO880376D0 (no) | 1988-01-28 |
| NO880376L true NO880376L (no) | 1988-01-28 |
Family
ID=25353468
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO880376A NO880376L (no) | 1986-05-30 | 1988-01-28 | D-gl konjugat-behandling. |
Country Status (8)
| Country | Link |
|---|---|
| EP (1) | EP0272278B1 (da) |
| JP (1) | JPS63503457A (da) |
| AT (1) | ATE90876T1 (da) |
| CA (1) | CA1309558C (da) |
| DE (1) | DE3786334T2 (da) |
| DK (1) | DK33488D0 (da) |
| NO (1) | NO880376L (da) |
| WO (1) | WO1987007145A1 (da) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6441025B2 (en) * | 1996-03-12 | 2002-08-27 | Pg-Txl Company, L.P. | Water soluble paclitaxel derivatives |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4191668A (en) * | 1977-02-03 | 1980-03-04 | Scripps Clinic And Research Foundation | Induction of immunological tolerance |
-
1986
- 1986-10-10 CA CA000520250A patent/CA1309558C/en not_active Expired - Lifetime
-
1987
- 1987-02-02 JP JP62501436A patent/JPS63503457A/ja active Pending
- 1987-02-02 WO PCT/US1987/000197 patent/WO1987007145A1/en not_active Ceased
- 1987-02-02 EP EP87901796A patent/EP0272278B1/en not_active Expired - Lifetime
- 1987-02-02 AT AT87901796T patent/ATE90876T1/de active
- 1987-02-02 DE DE87901796T patent/DE3786334T2/de not_active Expired - Fee Related
-
1988
- 1988-01-25 DK DK033488A patent/DK33488D0/da not_active Application Discontinuation
- 1988-01-28 NO NO880376A patent/NO880376L/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CA1309558C (en) | 1992-10-27 |
| DK33488A (da) | 1988-01-25 |
| JPS63503457A (ja) | 1988-12-15 |
| NO880376D0 (no) | 1988-01-28 |
| ATE90876T1 (de) | 1993-07-15 |
| EP0272278B1 (en) | 1993-06-23 |
| AU7082987A (en) | 1987-12-22 |
| EP0272278A4 (en) | 1990-01-08 |
| DE3786334D1 (de) | 1993-07-29 |
| DE3786334T2 (de) | 1993-12-02 |
| WO1987007145A1 (en) | 1987-12-03 |
| EP0272278A1 (en) | 1988-06-29 |
| DK33488D0 (da) | 1988-01-25 |
| AU604687B2 (en) | 1991-01-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK442688D0 (da) | Fremgangsmaade og praeparat til behandling af non-ige-medierede lidelser | |
| ES2194973T3 (es) | Transporte de inmunogenes transepitelial especifico del receptor. | |
| DK651689D0 (da) | Oralt autoantigenholdigt praeparat | |
| MY131095A (en) | Polyethylene protein conjugates. | |
| DE60039752D1 (de) | Herstellung tetravalenter antikörper | |
| DE69133516D1 (de) | Behandlung von autoimmunkrankheiten durch orale verabreichung von autoantigenen | |
| PT627933E (pt) | Supressao "bystander" de doencas autoimunes | |
| ATE245030T1 (de) | Antigen-besierende heteropolymere zur behandlung von autoimmunkrankheiten mittels diesen | |
| CY1108318T1 (el) | Διεγερση των κυτταρων τ εναντια στα δικα τους αντιγονα με τη χρηση των παραγοντων αποκλεισμου ctla-4 | |
| PT84841A (de) | Ungesattigte fettsauren enthaltende zubereitungen fuer die synthese von prostaglandinen und hydroxyfettsaueren in biologischen systemen | |
| PT954333E (pt) | Receptores soluveis de linfotoxina-beta, anticorpos de receptores de anti-linfotoxina e anticorpos de ligandos de anti-linfotoxina como agentes terapeuticos para o tratamento de doencas imunologicas | |
| DE3781652D1 (de) | Zubereitung, geeignet fuer die behandlung von darmstoerungen. | |
| GR3003388T3 (en) | Imidazolylguanidine derivatives, process for their preparation and medicines containing them | |
| NO880376L (no) | D-gl konjugat-behandling. | |
| ES8206855A1 (es) | Un procedimiento para la preparacion de anticuerpos con especialidad frente a antigenos encontrados en los nucleos y nu-cleolos de las celulas humanas cancerosas. | |
| NO986218L (no) | FremgangsmÕte til Õ bestemme nµrvµr av hjerneprotein S-100 | |
| ES2115582T3 (es) | Preparacion y aplicaciones de interferon-gamma. | |
| DE3670307D1 (de) | Spezifische mycoplasma-membran-antigene und -antikoerper sowie deren klinische verwendungen. | |
| RU97117537A (ru) | Мазь "черная" для лечения арахнозов, дерматомикозов и заболеваний кожи | |
| ES2061718T3 (es) | Utilizacion de antigestagenos para la preparacion de medicamentos. | |
| RU96119817A (ru) | Способ лечения дисбактериозов кишечника | |
| Burnyasheva et al. | On the question of the treatment of urticaria | |
| Ohata | Symposium II: Reconstruction of the Trachea Introduction | |
| FR2641182B1 (fr) | Appareil de traitement par influence sur les pavillons auriculaires d'un sujet humain ou animal, de champs electriques modules | |
| Tkachiv | Clinical and morphological aspects of mammary gland cancer combined therapy with the inter vascular blood irradiation use.; Klyinyiko-morfologyichnyi aspekti kombyinovanogo lyikuvannya raku molochnoyi zalozi z zastosuvannyam vnutrisudinnogo opromyinyuvannya krovyi. |